One of the authors of a controversial and now-retracted paper purporting a stem cell breakthrough has been found dead in what appears to be a suicide, according to numerous reports, following an investigation that has alarmed researchers and rattled one of Japan's most respected institutions.
Stem cells were once theorized to be a therapy in and of itself--a way to directly treat diseases or restore people's health from debilitating conditions. But scientists are now exploring how to use the cells indirectly to generate tissue or immune responses that can achieve the same goals.
Almost two years after first announcing plans to build a new stem cell research and manufacturing center close to the Canadian border in Vermont, a joint venture set up by South Korea's AnC Bio and a
In a fresh indication of Big Pharma's desire to tap into the future revenue potential presented by stem cell therapies, Pfizer has inked a $111 million deal to license rights to develop Athersys'
The SEC has filed a lawsuit against Bothell, WA-based CellCyte Genetics and two former executives for lying to investors regarding its stem cell therapies. The developer has already been in hot water
After developing a novel method to create cancer stem-like cells, researchers were able to identify a chemical that was a hundred times more effective than a common chemotherapy in destroying a key
Pfizer is revving up its engines to get those planned R&D changes into high gear. The drugmaker says it's pumping $100 million into its international stem cell development program. The company's
Following up on eight acute and chronic spinal cord injury patients who were injected with bone marrow stem cells two years ago, researchers say that the therapy proved safe and effective in
Osiris Therapeutics has hit a notable milestone, completing enrollment for a late-stage stem cell trial. Researchers will explore the benefits of Prochymal for steroid-refractory acute Graft versus
Voters in Michigan appeared on the verge of endorsing a proposal to allow researchers to use discarded embryos from fertility clinics to devise new embryonic stem cell lines. The proposal had been